Phase 2 Multi-centre Study of BromAc (bromelain + acetylcysteine) for Recurrent Peritoneal Mucinous Tumour / Pseudomyxoma Peritonei
Pseudomyxoma Peritonei · Peritoneal Cancer
Enrolment: 62 · Results not recorded
Loading the evidence…
Nutraceutical · Removal of necrotic tissue; mechanism not fully understood but thiol endopeptidases and escharase are present and may promote wound healing by removing necrotic tissue (FDA label)
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Pseudomyxoma Peritonei · Peritoneal Cancer
Enrolment: 62 · Results not recorded
Pseudomyxoma Peritonei
Enrolment: 10 · Results not recorded
Intracanal Medication
Enrolment: 30 · Results not recorded
Cardiovascular Disease
Enrolment: 72 · Results not recorded
2 studies reported at therapy level; 2 evidence entries itemised.
Model: Acute crush injury of Achilles tendon
Oral bromelain increased tenocyte proliferation in early tendon healing, without changing malondialdehyde.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Crush injury to the Achilles tendon
Bromelain significantly increased tenocyte proliferation versus control while pineapple juice significantly lowered malondialdehyde in early crush tendon healing.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.